FDA Expands Use of DESCRIBE PFD Patch for Laser Treatment of Tattoos

The Patch allows physicians to treat tattoos more efficiently by enabling rapid multiple laser passes in a single treatment session.
The Patch allows physicians to treat tattoos more efficiently by enabling rapid multiple laser passes in a single treatment session.

Merz North America announced that the DESCRIBE PFD Patch is now cleared for use with all commonly used lasers for tattoo removal.

The Food and Drug Administration (FDA) initially granted clearance in April 2015 for use with the 755nm QS Alexandrite laser, which effectively removes blue- or black ink tattoos. The expanded approval now includes the use of 532nm, 694nm, 755nm, and 1064nm standard Q-Switched (QS) lasers, as well as the 532nm, 755nm, 785nm, and 1064nm standard picosecond lasers in Fitzpatrick Skin Type I–III patients. This allows for the ability to remove tattoos for a spectrum of colors. 

The FDA clearance also includes an extended shelf life of the Patch from 2 years to 3 years. 

Related Articles

The single-use Patch is a perfluorodecalin-infused gel-based skin barrier and optical clearing device used for laser-assisted tattoo removal procedures. The dual-layer silicone patch is placed over tattoos before laser removal and allows physicians to treat tattoos more efficiently through rapid multiple laser passes in a single session. At the correct wavelength, the Patch can be used to help remove colored tattoos.

For more information call (844) 4MY-MERZ or visit DescribePatch.com.